Bone Marrow TransplantationTransplantation, HomologousHepatic Veno-Occlusive DiseaseGraft vs Host DiseaseBone MarrowWhole-Body IrradiationAnemia, AplasticLeukemiaBone Marrow CellsTransplantation ConditioningHematopoietic Stem Cell TransplantationTransplantation, AutologousBone and BonesT-LymphocytesMice, Inbred C57BLHematopoietic Stem CellsLiver TransplantationTransplantation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityTransplantation, IsogeneicCyclophosphamideBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceRadiation ChimeraCombined Modality TherapyImmunosuppressionTime FactorsBone Marrow ExaminationLeukemia, Myeloid, AcuteHematologic NeoplasmsImmunosuppressive AgentsRemission InductionTreatment OutcomeGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionRetrospective StudiesLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyColony-Forming Units AssayChimeraHLA AntigensSurvival AnalysisMyelodysplastic SyndromesLung TransplantationHematologic DiseasesCyclosporineLymphocyte TransfusionActuarial AnalysisBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineCell DifferentiationOrgan TransplantationPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectFollow-Up StudiesCytomegalovirus InfectionsLeukocyte CountCytarabineSurvival RateSpleenGranulocyte Colony-Stimulating FactorPostoperative ComplicationsMice, Inbred BALB CBone ResorptionMelphalanFlow CytometryDisease-Free SurvivalEtoposideLymphomaMultiple MyelomaCells, CulturedFatal OutcomeAntigens, CD34Mice, KnockoutHodgkin DiseaseCell TransplantationCord Blood Stem Cell TransplantationInfectionPrognosis